
Keywords: 2-AB; 2-aminobanzamide; AFP; α-fetoprotein; AGP; α1-acid glycoprotein; BMI; body mass index; CDG; congenital disorders of glycosylation; CEA; carcinoembryonic antigen; CRP; C-reactive protein; CVD; cardiovascular disease; DAS28; Disease Activity Score b